• Mutation; VGNC; VGNC:47719; TP53; Simple; p.Arg164His (c.491G>A); Zygosity=Homozygous (PubMed=31175136).
  

PubMed=10342286; DOI=10.1292/jvms.61.361
Barroga E.F., Kadosawa T., Okumura M., Fujinaga T.
Establishment and characterization of the growth and pulmonary metastasis of a highly lung metastasizing cell line from canine osteosarcoma in nude mice.
J. Vet. Med. Sci. 61:361-367(1999)

PubMed=21801068; DOI=10.2460/ajvr.72.8.1097
Stokol T., Daddona J.L., Mubayed L.S., Trimpert J., Kang S.
Evaluation of tissue factor expression in canine tumor cells.
Am. J. Vet. Res. 72:1097-1106(2011)

PubMed=23758893; DOI=10.1186/1746-6148-9-116; PMCID=PMC3684535
Milovancev M., Hilgart-Martiszus I.F., McNamara M.J., Goodall C.P., Seguin B., Bracha S., Wickramasekara S.I.
Comparative analysis of the surface exposed proteome of two canine osteosarcoma cell lines and normal canine osteoblasts.
BMC Vet. Res. 9:116.1-116.10(2013)

PubMed=27257868; DOI=10.1371/journal.pone.0156689; PMCID=PMC4892608
Maeda J., Froning C.E., Brents C.A., Rose B.J., Thamm D.H., Kato T.A.
Intrinsic radiosensitivity and cellular characterization of 27 canine cancer cell lines.
PLoS ONE 11:E0156689-E0156689(2016)

PubMed=27197945; DOI=10.1111/vco.12192; PMCID=PMC5656225
Fowles J.S., Dailey D.D., Gustafson D.L., Thamm D.H., Duval D.L.
The Flint Animal Cancer Center (FACC) canine tumour cell line panel: a resource for veterinary drug discovery, comparative oncology and translational medicine.
Vet. Comp. Oncol. 15:481-492(2017)

PubMed=31175136; DOI=10.1158/1535-7163.MCT-18-1346; PMCID=PMC6679748
Das S., Idate R., Cronise K.E., Gustafson D.L., Duval D.L.
Identifying candidate druggable targets in canine cancer cell lines using whole-exome sequencing.
Mol. Cancer Ther. 18:1460-1471(2019)

PubMed=31959767; DOI=10.1038/s41598-019-56878-x; PMCID=PMC6971036
Song Z.-F., Pearce M.C., Jiang Y., Yang L.-P., Goodall C.P., Miranda C.L., Milovancev M., Bracha S., Kolluri S.K., Maier C.S.
Delineation of hypoxia-induced proteome shifts in osteosarcoma cells with different metastatic propensities.
Sci. Rep. 10:727-727(2020)

PubMed=33446089; DOI=10.1177/1040638720985242; PMCID=PMC7944434
Ayers J., Milner R.J., Cortes-Hinojosa G., Riva A., Axiak-Bechtel S.M., Sahay B., Cascio M., Lejeune A., Shiomitsu K., Souza C., Hernandez O., Salute M.E.
Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines.
J. Vet. Diagn. Invest. 33:261-278(2021)

PubMed=36099278; DOI=10.1371/journal.pone.0274383; PMCID=PMC9469990
Megquier K., Turner-Maier J., Morrill K., Li X., Johnson J., Karlsson E.K., London C.A., Gardner H.L.
The genomic landscape of canine osteosarcoma cell lines reveals conserved structural complexity and pathway alterations.
PLoS ONE 17:E0274383-E0274383(2022)